RUS 3108 is being developed for the treatment of atherosclerosis, the major cause of cardiovascular disorders such as heart attacks and stroke by Dr. Reddy’s Laboratories. The drug’s Phase I clinical trials have been initiated in Europe to assess safety of the drug compound in healthy volunteers.

Synonyms: RUS 3108

This is just here as a test because I lose it

Term information

database cross reference
  • PubChem Substance:347910308
hasDbXref

PubChem Substance:347910308

inScheme

https://identifiers.org/drugbank

label

RUS 3108

Term relations

Subclass of: